Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythropoiesis”

152 trials

Showing 20 of 152 results

Post-approval studies (Phase 4)Study completedNCT03598582
What this trial is testing

Biological Predictive Factors of Response to ESA in Low Risk MDS Patients

Who this might be right for
Myelodysplastic Syndromes
Association pour la recherche sur les Affections Malignes en Immunologie Sanguine 70
Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Not applicableStudy completedNCT01666301
What this trial is testing

ESAs, Reticulocyte Dynamic and Hemoglobin Variability

Who this might be right for
Erythropoiesis Stimulating Agent Pharmacodynamics
Ospedale Regionale di Locarno 31
Post-approval studies (Phase 4)Study completedNCT04922645
What this trial is testing

Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

Who this might be right for
HyperphosphatemiaAnemia, Iron DeficiencyRenal Insufficiency
USRC Kidney Research 214
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Large-scale testing (Phase 3)WithdrawnNCT05082571
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Large-scale testing (Phase 3)Study completedNCT02964936
What this trial is testing

Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With Anemia

Who this might be right for
Chronic Kidney Disease
Astellas Pharma Inc 100
Not applicableApproved For MarketingNCT05937568
What this trial is testing

Expanded Access for Treatment With Imetelstat

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation
Post-approval studies (Phase 4)Ended earlyNCT02213653
What this trial is testing

Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency

Who this might be right for
Solid Cancer Metastatic DiseaseLymphoid Disease
Centre Francois Baclesse 24
Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Not applicableStudy completedNCT01755455
What this trial is testing

Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis

Who this might be right for
Cystic FibrosisAnemia, Iron-Deficiency
Dartmouth-Hitchcock Medical Center 22
Not applicableStudy completedNCT03481686
What this trial is testing

Therapeutic Education of Chronic Renal or Renal Transplant Patient in the Management of EPO Injections

Who this might be right for
Renal Insufficiency, ChronicOrgan Graft
Rennes University Hospital 9
Not applicableEnded earlyNCT01546337
What this trial is testing

Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesAnemiaHemopathies
Rennes University Hospital 30
Large-scale testing (Phase 3)WithdrawnNCT03242967
What this trial is testing

Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics
Not applicableStudy completedNCT02134119
What this trial is testing

Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes

Who this might be right for
Ineffective Erythropoiesis
University of Georgia 45
Large-scale testing (Phase 3)Active Not RecruitingNCT02598661
What this trial is testing

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation 289
Large-scale testing (Phase 3)Study completedNCT00557817
What this trial is testing

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Hematological Malignancies
University of Liege 125
Testing effectiveness (Phase 2)Ended earlyNCT00109291
What this trial is testing

Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 17
Large-scale testing (Phase 3)Active Not RecruitingNCT03682536
What this trial is testing

Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve

Who this might be right for
Myelodysplastic Syndromes
Celgene 363
Not applicableEnded earlyNCT01890577
What this trial is testing

Study of South African Dialysis Patients

Who this might be right for
Chronic Kidney Disease, Receiving Dialysis
Amgen 28
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation